NASDAQ:PMCB | Free Cash Flow | PharmaCyte Biotech, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-04-30 to 2026-04-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-04-30-$1.39M
2025-07-31-$1.99M
2025-04-30-$1.04M
2024-07-31-$373,297.00
2024-04-30-$332,958.00
2023-07-31$342,959.00
2023-04-30-$288,388.00
2022-07-31-$1.08M
2022-04-30-$1.19M
2021-07-31-$1.24M
2021-04-30-$940,303.00
2020-07-31-$551,002.00
2020-04-30-$639,392.00
2019-07-31-$763,140.00
2019-04-30-$661,363.00
2018-07-31-$622,243.00
2018-04-30-$1.37M
2017-07-31-$935,567.00
2017-04-30-$800,887.00
2016-07-31-$906,928.00
2016-04-30-$1.22M
2015-07-31-$1.06M
2015-04-30-$1.09M
2014-07-31-$786,814.00
2014-04-30-$938,240.00
2013-07-31-$159,674.00
2013-04-30-$142,951.00
2012-07-31-$85,388.00
2012-04-30-$51,955.00
2011-07-31-$119,627.00
2011-04-30-$141,871.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-04-30-$5.15M
2025-04-30-$2.98M
2024-04-30-$2.15M
2023-04-30-$3.79M
2022-04-30-$4.12M
2021-04-30-$3.33M
2020-04-30-$2.34M
2019-04-30-$2.88M
2018-04-30-$5.08M
2017-04-30-$3.34M
2016-04-30-$4.35M
2015-04-30-$4.56M
2014-04-30-$1.55M
2013-04-30-$390,426.00
2012-04-30-$259,289.00
2011-04-30-$225,232.00